Sutro Biopharma, Inc.STRONASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank89
3Y CAGR+15.6%
5Y CAGR+51.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+15.6%/yr
vs +25.6%/yr prior
5Y CAGR
+51.2%/yr
Recent deceleration
Acceleration
-10.0pp
Decelerating
Percentile
P89
Within normal range
vs 5Y Ago
7.9x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $291.22M | -0.7% |
| 2024 | $293.28M | +24.2% |
| 2023 | $236.19M | +25.3% |
| 2022 | $188.43M | +25.1% |
| 2021 | $150.63M | +309.1% |
| 2020 | $36.82M | -62.5% |
| 2019 | $98.20M | +29.8% |
| 2018 | $75.64M | +6.5% |
| 2017 | $71.01M | +21.7% |
| 2016 | $58.37M | - |